Question: is juxtapid a pcsk9 inhibitor?
Answer: function of the proteolytic enzyme PCSK9 Lomitapide (Juxtapid® and Lojuxta®; Aegerion Pharmaceuticals, Inc., MA, USA), an orally administered inhibitor of the microsomal triglyceride transfer protein, inhibits the synthesis and secretion of ApoB‑containing lipoproteins and, thus, reduces plasma levels of low‑density ...